Biosimilar Production
Samsung Biologics Secures $411 Million Long-Term Deal with Pfizer for Biosimilar Production
SG Tylor
South Korea’s Samsung Biologics has recently entered into another significant manufacturing agreement, this time with Pfizer, worth $411 million. The ...
